Table 3.
Efficiency measures results of treatment in clinic.
| PD | MS | Stroke | Comparison [Test(p)] | All | |
|---|---|---|---|---|---|
| TIME 1: ClinicHEAD | |||||
| N | 30 | 32 | 45 | – | 107 |
| Adherence | 0.93 ± 0.11 | 0.90 ± 0.18 | 0.94 ± 0.10 | 1.23(0.296)* | 0.92 ± 0.13 |
| Duration of treatment (M ± sd) | |||||
| Number of activities | 4.54 ± 1.70 | 4.97 ± 1.39 | 4.16 ± 0.88 | 0.90(0.408)* | 4.51 ± 1.34 |
| Duration of session, min | 39.62 ± 18.14 | 43.70 ± 18.54 | 36.81 ± 13.05 | 0.40(0.675)* | 39.65 ± 16.42 |
| SUS (Median, 25–75 percentile) | 68.75, 60.00–82.50 | 75.00, 62.50–84.38 | 70.00, 62.50–80.63 | 0.77 (0.679)§ | 70.00, 62.50–82.50 |
| Usability | 2.88, 2.63–3.29 |
3.14, 2.75–3.43 |
3.00, 2.63–3.38 |
1.64 (0.440)§ | 3.00, 2.63–3.43 |
| Learnability | 3.00, 1.50–3.50 |
2.50, 1.50–3.50 |
2.50, 1.50–3.50 |
0.99 (0.605)§ | 2.50, 1.50–3.50 |
| TAM3 (M ± sd) | |||||
| Usefulness | 5.54 ± 1.36 | 5.08 ± 1.58 | 5.50 ± 1.31 | 2.82(0.065)* | 5.39 ± 1.41 |
| Ease of use | 5.59 ± 0.92 | 5.53 ± 1.09 | 5.55 ± 1.12 | 0.28(0.760)* | 5.55 ± 1.05 |
| External control | 5.05 ± 0.92 | 4.93 ± 1.39 | 4.86 ± 1.15 | 0.77(0.466)* | 4.94 ± 1.17 |
| Relevance | 5.84 ± 1.51 | 5.30 ± 1.40 | 5.84 ± 0.99 | 1.37(0.260)* | 5.68 ± 1.29 |
| Enjoyment | 5.67 ± 1.33 | 5.91 ± 1.02 | 5.56 ± 1.66 | 0.47(0.629)* | 5.70 ± 1.40 |
| TIME 2: HomeHEAD | |||||
| N | 11 | 14 | 13 | – | 38 |
| Adherence | 0.86 ± 0.14 | 0.66 ± 0.28 | 0.82 ± 0.15 | 6.00(0.007)* | 0.77 ± 0.22 |
| Duration of treatment (M ± sd) | |||||
| Number of activities | 3.88 ± 0.90 | 4.03 ± 0.83 | 3.24 ± 0.42 | 0.81 (0.457)* | 3.72 ± 0.80 |
| Duration of session, min | 37.74 ± 7.61 | 37.57 ± 9.89 | 30.66 ± 5.67 | 0.72 (0.497)* | 35.17 ± 8.47 |
| SUS (Median, 25–75 percentile) | 85.00, 77.50–92.50 | 67.50, 55.00–85.00 | 80.00, 68.13–84.38 | 3.14 (0.205)* | 80.00, 67.50–85.00 |
| Usability | 3.36, 3.25–3.71 |
2.86, 2.42–3.43 |
3.13, 2.65–3.50 |
2.46 (0.292)* | 3.20, 2.57–3.50 |
| Learnability | 4.00, 2.50–4.00 |
2.50, 1.50–3.63 |
3.00, 2.63–3.88 |
3.06 (0.195)* | 3.00, 2.00–4.00 |
| TAM3 (M ± sd) | |||||
| Usefulness | 5.25 ± 1.97 | 5.23 ± 1.11 | 5.53 ± 0.10 | 1.47(0.254)* | 5.33 ± 1.29 |
| Ease of use | 4.68 ± 1.10 | 5.75 ± 1.21 | 5.65 ± 1.01 | 2.18(0.139)* | 5.45 ± 1.17 |
| External control | 4.89 ± 0.45 | 4.95 ± 1.27 | 5.38 ± 0.95 | 0.50(0.613)* | 5.07 ± 1.01 |
| Relevance | 5.62 ± 1.50 | 5.50 ± 1.10 | 6.04 ± 0.90 | 0.50(0.616)* | 5.70 ± 1.13 |
| Enjoyment | 6.00 ± 1.29 | 5.97 ± 0.10 | 6.06 ± 1.14 | 0.97 (0.396)* | 6.01 ± 1.08 |
M, mean; MS, multiple sclerosis; N, number; PD, Parkinson Disease; sd, standard deviation; SUS, System Usability Scale; TAM3, Technology Acceptance Model-3.
*
ANCOVA comparison was performed co-varying recruiting center, age, gender, education;
§
Kruskall-Wallis test was performed.